Palouse Capital Management Inc. Has $2.45 Million Stake in Lam Research Corporation $LRCX

Palouse Capital Management Inc. lowered its holdings in Lam Research Corporation (NASDAQ:LRCX) by 20.1% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 25,119 shares of the semiconductor company’s stock after selling 6,323 shares during the quarter. Lam Research comprises about 1.6% of Palouse Capital Management Inc.’s investment portfolio, making the stock its 29th largest position. Palouse Capital Management Inc.’s holdings in Lam Research were worth $2,445,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Brighton Jones LLC boosted its position in Lam Research by 1,032.4% in the 4th quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock valued at $1,025,000 after buying an additional 12,936 shares during the last quarter. Alps Advisors Inc. raised its holdings in Lam Research by 294.2% during the 1st quarter. Alps Advisors Inc. now owns 17,537 shares of the semiconductor company’s stock worth $1,275,000 after purchasing an additional 13,088 shares during the last quarter. Mutual of America Capital Management LLC bought a new position in shares of Lam Research in the 1st quarter valued at about $13,345,000. Stephens Inc. AR grew its position in shares of Lam Research by 55.0% during the 1st quarter. Stephens Inc. AR now owns 9,603 shares of the semiconductor company’s stock worth $698,000 after buying an additional 3,409 shares during the period. Finally, Westmount Partners LLC acquired a new stake in Lam Research during the 1st quarter worth $225,000. 84.61% of the stock is owned by institutional investors.

Insider Activity

In related news, insider Ava Harter sold 9,010 shares of the firm’s stock in a transaction on Monday, October 27th. The shares were sold at an average price of $157.47, for a total value of $1,418,804.70. Following the completion of the transaction, the insider directly owned 56,786 shares of the company’s stock, valued at approximately $8,942,091.42. This trade represents a 13.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Bethany Mayer sold 1,298 shares of the stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total transaction of $207,667.02. Following the completion of the sale, the director owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. This represents a 44.00% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 62,528 shares of company stock valued at $8,880,448. 0.31% of the stock is owned by insiders.

Analyst Ratings Changes

A number of research analysts recently issued reports on LRCX shares. Evercore ISI boosted their price objective on shares of Lam Research from $115.00 to $170.00 and gave the company an “outperform” rating in a report on Thursday, October 23rd. Raymond James Financial lifted their target price on Lam Research from $90.00 to $110.00 and gave the stock an “outperform” rating in a report on Thursday, July 31st. UBS Group set a $165.00 price target on Lam Research and gave the stock a “buy” rating in a report on Thursday, October 23rd. Erste Group Bank started coverage on Lam Research in a report on Thursday, August 14th. They set a “buy” rating on the stock. Finally, Barclays set a $142.00 price objective on Lam Research and gave the company an “equal weight” rating in a research report on Monday, October 20th. One analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, Lam Research presently has a consensus rating of “Moderate Buy” and a consensus price target of $148.54.

Lam Research Price Performance

Shares of LRCX opened at $166.37 on Tuesday. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $167.15. The stock has a market capitalization of $208.97 billion, a P/E ratio of 36.65, a P/E/G ratio of 1.68 and a beta of 1.87. The company has a 50 day moving average of $136.27 and a 200-day moving average of $107.57.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.04. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company’s revenue was up 27.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, equities research analysts forecast that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be paid a dividend of $0.26 per share. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.6%. Lam Research’s dividend payout ratio is currently 22.91%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.